Last reviewed · How we verify
Esophageal Cancer
Approved treatments
- Tevimbra · Beigene
Tevimbra blocks the PD-1 receptor, allowing the immune system to recognize and attack cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Esophageal Cancer patent landscape — cliff calendar, originator estates, attackable patents
- Esophageal Cancer treatment landscape brief
- Esophageal Cancer treatment updates RSS
Frequently asked questions about Esophageal Cancer
What drugs treat Esophageal Cancer?
Tracked treatments include Tevimbra.
What is the treatment for Esophageal Cancer?
Standard treatment for Esophageal Cancer includes Tevimbra. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Esophageal Cancer patent cliff · Esophageal Cancer CI report
- Treatment: Tevimbra · Beigene
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing